Nuclera: Venture Capital Funding History

Nuclera lands £9m Series C extension led by Elevage Medical Technologies to speed up synthesising functional proteins

Nuclera builds benchtop protein discovery systems that allow researchers to rapidly express, purify and analyse functional proteins and antibodies in-house, reducing time, cost and uncertainty in early-stage biologics research.